This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Aug 30;362(9385):744; author reply 744-5.

doi: 10.1016/S0140-6736(03)14213-4.

Comments on the MRC/BHF Heart Protection Study

Cesare R Sirtori

PMID: 12957102
DOI: 10.1016/S0140-6736(03)14213-4

Comment

Comments on the MRC/BHF Heart Protection Study

Cesare R Sirtori. Lancet. 2003.

. 2003 Aug 30;362(9385):744; author reply 744-5.

doi: 10.1016/S0140-6736(03)14213-4.

Author

Cesare R Sirtori

PMID: 12957102
DOI: 10.1016/S0140-6736(03)14213-4

No abstract available

PubMed Disclaimer

Comment on

Major benefits from cholesterol-lowering in patients with diabetes.
Lindholm LH. Lindholm LH. Lancet. 2003 Jun 14;361(9374):2000-1. doi: 10.1016/S0140-6736(03)13672-0. Lancet. 2003. PMID: 12814705 No abstract available.
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.
Collins R, Armitage J, Parish S, Sleigh P, Peto R; Heart Protection Study Collaborative Group. Collins R, et al. Lancet. 2003 Jun 14;361(9374):2005-16. doi: 10.1016/s0140-6736(03)13636-7. Lancet. 2003. PMID: 12814710 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science